Intra-tumoral injection of doxorubicin (Adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects

International Journal of Cancer

Volumn 88, Issue 4, 2000, Pages 645-651

  Idani, Hitoshi ^a   Matsuoka, Junji ^a   Yasuda, Tatsuji ^a   Kobayashi, Kazuko ^a   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TISSUE LEVEL; HISTOLOGY; INTERMETHOD COMPARISON; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TISSUE INJURY; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; BODY WEIGHT; DOXORUBICIN; DRUG CARRIERS; FIBROSARCOMA; INJECTIONS; LIPOSOMES; MALE; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS; TISSUE DISTRIBUTION;

EID: 0033761262     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20001115)88:4<645::AID-IJC20>3.0.CO;2-4     Document Type: Article

References (30)

1. Subcutaneous administration of liposomes: A comparison with the intravenous and intraperitoneal routes of injection
2. Tissue distribution and disposition of daunomycin in mice: Fluorometric and isotopic methods
3. Improvement of combined modality therapy with cisplatin and radiation using intra-tumoral drug administration in murine tumors
4. Intra-tumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: A multicenter pilot study
5. Adriamycin (NSC-123127) - Thoughts for the future
6. Injectable modalities as local and regional strategies for head and neck cancer
7. Liposomes as in vivo carriers of Adriamycin: Reduced cardiac uptake and preserved anti-tumor activity in mice
8. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors
9. Protocols for screening chemical agents and natural products against animal tumors and other biological systems (third edition)
10. A phase II study of pegylated liposomal doxorubicin for treatment of advanced hepatocellular carcinoma
11. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: Is surface coating with polyethylene glycol beneficial?
12. Liposome as drug carders in cancer therapy
13. Anti-tumor effect of Adriamycin entrapped in liposomes conjugated with anti-human α-fetoprotein monoclonal antibody
14. Doxil extravasation injury: A case report
15. Differential endocytosis and T and B lymphocyte surface molecules evaluated with antibody-bearing fluorescent liposomes containing methotrexate
16. Lack of vesicant injury following extravasation of liposomal doxorubicin
17. Direct injection of liposome-encapsulated doxorubicin optimizes chemomyectomy in rabbit eyelid
18. Adriamycin (NSC-123127) - Cardiomyopathy: An overview with determination of risk factors
19. Continuous intra-tumoral infusion of methotrexate for recurrent glioblastoma: A pilot study
20. Characterization, toxicity and therapeutic efficacy of Adriamycin encapsulated in liposomes
21. The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two anti-tumor drugs
22. Accumulation of liposomal lipid and encapsulated doxorubicin in m,urine Lewis lung carcinoma: The lack of beneficial effects by coating liposomes with poly(ethylene glycol)
23. Skin ulcers due to Adriamycin
24. Phase II trial of high-dose liposome encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer
25. Improvement of pharmacokinetics and anti-tumor activity against human hepatoma cell line by using Adriamycin-entrapped stealth liposomes
26. Efficient encapsulation of water soluble materials into small-sized liposomes
27. Therapy of a xenografted human colonic carcinoma using cisplatin or doxorubicin encapsulated in long-circulating pegylated stealth liposomes
28. Effect of sulfatide-inserted liposomes containing entrapped Adriamycin on metastasized cells in lymph nodes
29. The anthracycline antineoplastic drugs